Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

COVID-19 × bemcentinib × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1 Other hematologic neoplasm 1 Myeloid 1 Gastrointestinal 1 Dermatologic 1 CNS 1

Conditions

Pancreatic Neoplasms 1 Myelodysplastic Syndromes 1 Mesothelioma, Malignant 1 Melanoma 1 Leukemia, Myeloid, Acute 1 Glioblastoma 1 Carcinoma, Non-Small-Cell Lung 1 COVID-19 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06469138 2025-01-29

8479217

BerGenBio ASA

Phase 1 Completed

6 enrolled 17 charts

CNSDermatologicGastrointestinalMyeloidOther hematologic neoplasmOther solid neoplasmThoracic

Mesothelioma, Malignant, COVID-19, Carcinoma, Non-Small-Cell Lung, Glioblastoma, Melanoma, Myelodysplastic Syndromes, Pancreatic Neoplasms, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡